MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 5 (2008), Issue 11 (November)

1. Methicillin-resistant Staphylococcus aureus in orthopaedic surgery.
   J Bone Joint Surg Br, 90(11): 1401-6. [Abstract] [Full-text]
2. The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis.
   Pediatr Pulmonol, 43(11): 1117-23. [Abstract] [Full-text]
3. Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum beta-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study.
   Eur J Clin Microbiol Infect Dis, 27(11): 1113-7. [Abstract] [Full-text]
4. The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era.
   HIV Med, 9(10): 858-62. [Abstract] [Full-text]
5. How to handle a CA-MRSA outbreak.
   Dermatol Clin, 27(1): 43-8. [Abstract] [Full-text]
6. Topical antibiotics in dermatology: emerging patterns of resistance.
   Dermatol Clin, 27(1): 25-31. [Abstract] [Full-text]
7. Fact or infection: do surgical trainees know enough about infection control?
   Ann R Coll Surg Engl, 90(8): 647-50. [Abstract] [Full-text]
8. Nanomechanical detection of antibiotic-mucopeptide binding in a model for superbug drug resistance.
   Nat Nanotechnol, 3(11): 691-6. [Abstract] [Full-text]
9. Screening of Chinese medicinal plants for inhibition against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
   J Ethnopharmacol, 120(2): 287-90. [Abstract] [Full-text]
10. Comparison of the effect of ciprofloxacin and Tazocin on the incidence of meticillin-resistant Staphylococcus aureus (MRSA) in an Intensive Care Unit.
    Int J Antimicrob Agents, 32(6): 499-504. [Abstract] [Full-text]
11. Efficacy of collagen silver-coated polyester and rifampin-soaked vascular grafts to resist infection from MRSA and Escherichia coli in a dog model.
    Ann Vasc Surg, 22(6): 815-21. [Abstract] [Full-text]
12. Prevalence, risk factors, and molecular epidemiology of methicillin-resistant Staphylococcus aureus among newly arrested men in Baltimore, Maryland.
    Am J Infect Control, 36(9): 644-50. [Abstract] [Full-text]
13. Dermatologists' perceptions and practices related to community-associated methicillin-resistant Staphylococcus aureus infections.
    Am J Infect Control, 36(9): 668-71. [Abstract] [Full-text]
14. The role of molecular methods in the prevention of nosocomial methicillin-resistant Staphylococcus aureus clusters in cancer patients.
    Am J Infect Control, 36(9): 656-60. [Abstract] [Full-text]
15. Consideration to culture health care workers related to increased methicillin-resistant Staphylococcus aureus activity in a neonatal intensive care unit.
    Am J Infect Control, 36(9): 638-43. [Abstract] [Full-text]
16. Methicillin-resistant Staphylococcus aureus and skin infections among personnel at a pediatric clinic.
    Am J Infect Control, 36(9): 665-7. [Abstract] [Full-text]
17. Impact of an antimicrobial-impregnated gauze dressing on surgical site infections including methicillin-resistant Staphylococcus aureus infections.
    Am J Infect Control, 36(9): 651-5. [Abstract] [Full-text]
18. Monitoring and feedback of hand hygiene compliance and the impact on facility-acquired methicillin-resistant Staphylococcus aureus.
    Am J Infect Control, 36(9): 672-7. [Abstract] [Full-text]
19. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008.
    Am J Infect Control, 36(9): 627-37. [Abstract] [Full-text]
20. Trends in antibacterial use in US academic health centers: 2002 to 2006.
    Arch Intern Med, 168(20): 2254-60. [Abstract] [Full-text]
21. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia.
    Arch Intern Med, 168(20): 2205-10. [Abstract] [Full-text]
22. Artificial urinary sphincter infection: causative organisms in a contemporary series.
    J Urol, 180(6): 2475-8. [Abstract] [Full-text]
23. The evolution of Staphylococcus aureus.
    Infect Genet Evol, 8(6): 747-63. [Abstract] [Full-text]
24. High occurrence of methicillin-resistant Staphylococcus aureus ST398 in equine nasal samples.
    Vet Microbiol, 133(1): 138-44. [Abstract] [Full-text]
25. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.
    J Antimicrob Chemother, 62(6): 1413-21. [Abstract] [Full-text]
26. Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted time-series analysis.
    J Antimicrob Chemother, 62(6): 1422-9. [Abstract] [Full-text]
27. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother, 62(6): 1305-10. [Abstract] [Full-text]
28. Reversal of methicillin resistance in Staphylococcus aureus by thioridazine.
    J Antimicrob Chemother, 62(6): 1215-21. [Abstract] [Full-text]
29. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets.
    J Antimicrob Chemother, 62(6): 1301-4. [Abstract] [Full-text]
30. Methicillin-resistant Staphylococcus aureus and animals: zoonosis or humanosis?
    J Antimicrob Chemother, 62(6): 1181-7. [Abstract] [Full-text]
31. In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.
    J Antimicrob Chemother, 62(6): 1326-31. [Abstract] [Full-text]
32. Surprising Alteration of Antibacterial Activity of 5''-Modified Neomycin against Resistant Bacteria.
    J Med Chem. [Abstract] [Full-text]
33. Unrecognized burden of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus carriage in the pediatric intensive care unit.
    Infect Control Hosp Epidemiol, 29(12): 1174-6. [Abstract] [Full-text]
34. Colonization and/or infection with methicillin-resistant Staphylococcus aureus after living donor liver transplantation: a case control study.
    BMC Infect Dis, 8(1): 155. [Abstract] [Full-text]
35. Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model.
    Antimicrob Agents Chemother, 52(12): 4370-3. [Abstract] [Full-text]
36. Multisensitive community-acquired methicillin-resistant Staphylococcus aureus infections in Malaysia.
    Diagn Microbiol Infect Dis, 62(4): 437-9. [Abstract] [Full-text]
37. In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
    Antimicrob Agents Chemother, 52(12): 4442-7. [Abstract] [Full-text]
38. Chemical composition, antimicrobial and antioxidant activities of the essential oil and the ethanol extract of Cleistocalyx operculatus (Roxb.) Merr and Perry buds.
    Food Chem Toxicol, 46(12): 3632-9. [Abstract] [Full-text]
39. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
    Antimicrob Agents Chemother, 52(12): 4289-99. [Abstract] [Full-text]
40. Detection of staphylococcal cassette chromosome mec-associated DNA segments in multiresistant methicillin-susceptible Staphylococcus aureus (MSSA) and identification of Staphylococcus epidermidis ccrAB4 in both methicillin-resistant S. aureus and MSSA.
    Antimicrob Agents Chemother, 52(12): 4407-19. [Abstract] [Full-text]
41. Development of a digital microfluidic platform for point of care testing.
    Lab Chip, 8(12): 2091-104. [Abstract] [Full-text]
42. Polyhexamethylene guanidine hydrochloride-based disinfectant: a novel tool to fight meticillin-resistant Staphylococcus aureus and nosocomial infections.
    J Med Microbiol, 57: 1523-8. [Abstract] [Full-text]
43. Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center.
    Antimicrob Agents Chemother, 52(12): 4510-3. [Abstract] [Full-text]
44. Changing epidemiology of meticillin-resistant S. aureus in Queensland, Australia, 2000-2006: use of passive surveillance of susceptibility phenotypes.
    J Hosp Infect, 70(4): 305-13. [Abstract] [Full-text]
45. Epidemiology of community-acquired meticillin-resistant Staphylococcus aureus obtained from the UK West Midlands region.
    J Hosp Infect, 70(4): 314-20. [Abstract] [Full-text]
46. How clean is clean? Proposed methods for hospital cleaning assessment.
    J Hosp Infect, 70(4): 328-34. [Abstract] [Full-text]
47. Cost-effectiveness of telavancin versus vancomycin for treatment of complicated skin and skin structure infections.
    Pharmacotherapy, 28(12): 1471-82. [Abstract] [Full-text]
48. Structure and specific detection of staphylococcal cassette chromosome mec type VII.
    Biochem Biophys Res Commun, 377(3): 752-6. [Abstract] [Full-text]
49. Antibacterial effects of green tea polyphenols on clinical isolates of methicillin-resistant Staphylococcus aureus.
    Curr Microbiol, 57(6): 542-6. [Abstract] [Full-text]
50. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization.
    Br J Dermatol, 159(6): 1290-9. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.